Rabbit anti-JMJD1A/JHDM2A Antibody Affinity Purified
Product Details
Specifications
The epitope recognized by A301-538A-T maps to a region between residue 1025 and 1075 of human jumonji domain containing 1A (JmjC domain-containing histone demethylation protein 2A) using the numbering given in entry NP_060903.2 (GeneID 55818).
Immunoglobulin concentration was determined using Beer’s Law where 1mg/mL IgG has an A280 of 1.4. Antibody was affinity purified using an epitope specific to JMJD1A/JHDM2A immobilized on solid support.
The epitope recognized by A301-538A maps to a region between residue 1025 and 1075 of human jumonji domain containing 1A (JmjC domain-containing histone demethylation protein 2A) using the numbering given in entry NP_060903.2 (GeneID 55818).
Immunoglobulin concentration was determined using Beer’s Law where 1mg/mL IgG has an A280 of 1.4.
Additional Product Information
JMJD1A/JHDM2A is a member of the jumonji (jmj) domain containing gene family of histone demethylases that plays a role in the regulation of chromatin dynamics and influences transcriptional activation and suppression. JMJD1A/JHDM2A specifically demethylates mono- and dimethyl-histone 3 lysine 9. Demethylation of histones by JMJD1A has been shown to facilitate transcriptional activation by the androgen receptor and promote transcription of smooth muscle cell differentiation marker.
Alternate Names
JHDM2A; JHMD2A; jmjC domain-containing histone demethylation protein 2A; JMJD1; JMJD1A; jumonji C domain-containing histone demethylase 2A; jumonji domain-containing protein 1A; lysine (K)-specific demethylase 3A; lysine-specific demethylase 3A; testis-specific protein A; TSGA
Applications
All western blot analysis is performed using 5% Milk-TBST for blocking and as antibody diluent. Primary antibody is incubated overnight.
Western blots of immunoprecipitates are performed using Goat anti-Rabbit Light Chain HRP Conjugate (Cat. No. A120-113P) with 5% Normal Pig Serum (Cat. No. S100-020) added to the blocking buffer.